{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:08:46Z","timestamp":1774127326646,"version":"3.50.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Wuhan Natural Science Foundation-Exploration","award":["2024040801020355"],"award-info":[{"award-number":["2024040801020355"]}]},{"name":"Key Laboratory Open Project of Hubei Province-Seed Fund","award":["2024KFZ022"],"award-info":[{"award-number":["2024KFZ022"]}]},{"name":"Health Science and Technology Project of Hubei Province","award":["WJ2025Q028"],"award-info":[{"award-number":["WJ2025Q028"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Patients with Type 2 diabetes (T2D) are at an elevated risk of peripheral artery disease (PAD) compared with the general population. This study aimed to investigate whether joint risk factor control could mitigate the T2D-related excess risk of PAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This study included 14 458 participants with T2D who were initially free of cardiovascular disease and PAD and matched them with 56 961 control individuals from the UK Biobank cohort. Participants with T2D were categorized according to the number of risk factors controlled, including no current smoking, being physically active, healthy diet, and guideline-recommended levels of glycated haemoglobin, body mass index, blood pressure, LDL cholesterol, and urinary albumin. During a median follow-up of 11.9 years, 408 (2.8%) participants with T2D and 671 (1.2%) matched non-T2D individuals developed PAD. Among participants with T2D, a greater number of controlled risk factors were associated with lower PAD incidence (\u223c23% lower risk per additional factor). Compared with the matched non-T2D individuals, the hazard ratio [95% confidence interval (CI)] for PAD among participants with T2D gradually decreased from 2.49 (1.94, 3.19) for those with \u22642 risk factors controlled to 0.82 (0.51, 1.31) for those with \u22656 risk factors controlled. At 45 years of age, the difference in PAD-free survival time was on average \u22121.41 (95% CI \u22121.78, \u22121.03) years for participants with T2D who had \u22642 risk factors controlled and \u22120.11 (95% CI \u22120.38, 0.16) years for those who had \u22656 risk factors controlled compared with the non-T2D individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Individuals with T2D who achieved optimal risk factor control had no excess risk of PAD than matched non-T2D counterparts. Efforts to promote comprehensive risk factor management in T2D are imperative for reducing the burden of PAD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwaf697","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:23:04Z","timestamp":1761830584000},"source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive risk factor control in Type 2 diabetes and incident peripheral artery disease"],"prefix":"10.1093","author":[{"given":"Xiaohui","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Vascular Surgery, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan, Hubei 430060 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Lian","sequence":"additional","affiliation":[{"name":"Wuhan Pulmonary Hospital, Wuhan Institute for Tuberculosis Control , Wuhan 430060 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1601-1084","authenticated-orcid":false,"given":"Jinyi","family":"Wu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Public Health Safety of Ministry of Education, School of Public Health, Fudan University , Shanghai ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan, Hubei 430060 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0219-0480","authenticated-orcid":false,"given":"Sizheng","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan, Hubei 430060 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"2025111708222466900_zwaf697-B1","doi-asserted-by":"crossref","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"2025111708222466900_zwaf697-B2","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"2025111708222466900_zwaf697-B3","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"key":"2025111708222466900_zwaf697-B4","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMcp1507631","article-title":". Peripheral artery disease","volume":"374","author":"Kullo","year":"2016","journal-title":"N Engl J Med"},{"key":"2025111708222466900_zwaf697-B5","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2025111708222466900_zwaf697-B6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/eurjpc\/zwad072","article-title":"Risk factor variability and cardiovascular risk among patients with diabetes: a nationwide observational study","volume":"30","author":"Ceriello","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2025111708222466900_zwaf697-B7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjpc\/zwad381","article-title":"Global epidemiology of lower extremity artery disease in the 21st century (2000-21): a systematic review and meta-analysis","volume":"31","author":"Adou","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2025111708222466900_zwaf697-B8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/eurjpc\/zwae221","article-title":"Differences in the association of lifestyle-related modifiable risk factors with incident cardiovascular disease between individuals with and without diabetes","volume":"32","author":"Komuro","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"2025111708222466900_zwaf697-B9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes","volume":"379","author":"Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"2025111708222466900_zwaf697-B10","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/CIRCULATIONAHA.120.046783","article-title":"Risk factor control and cardiovascular event risk in people with type 2 diabetes in primary and secondary prevention settings","volume":"142","author":"Wright","year":"2020","journal-title":"Circulation"},{"key":"2025111708222466900_zwaf697-B11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12916-024-03343-w","article-title":"Assessing the impact of type 2 diabetes on mortality and life expectancy according to the number of risk factor targets achieved: an observational study","volume":"22","author":"Wang","year":"2024","journal-title":"BMC Med"},{"key":"2025111708222466900_zwaf697-B12","doi-asserted-by":"crossref","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"2025111708222466900_zwaf697-B13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","article-title":"Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association\u2019s strategic Impact Goal through 2020 and beyond","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"key":"2025111708222466900_zwaf697-B14","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"2025111708222466900_zwaf697-B15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"2025111708222466900_zwaf697-B16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/CIRCULATIONAHA.115.018585","article-title":"Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"2025111708222466900_zwaf697-B17","doi-asserted-by":"crossref","first-page":"e2336","DOI":"10.1212\/WNL.0000000000201231","article-title":"Association of combined healthy lifestyle factors with incident dementia in patients with type 2 diabetes","volume":"99","author":"Wang","year":"2022","journal-title":"Neurology"},{"key":"2025111708222466900_zwaf697-B18","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41591-019-0492-5","article-title":"Genome-wide association study of peripheral artery disease in the Million Veteran Program","volume":"25","author":"Klarin","year":"2019","journal-title":"Nat Med"},{"key":"2025111708222466900_zwaf697-B19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3348\/kjr.2022.0061","article-title":"Restricted mean survival time for survival analysis: a quick guide for clinical researchers","volume":"23","author":"Han","year":"2022","journal-title":"Korean J Radiol"},{"key":"2025111708222466900_zwaf697-B20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b79 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025111708222466900_zwaf697-B21","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1093\/eurheartj\/eht142","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy\u2014part II","volume":"34","author":"Beckman","year":"2013","journal-title":"Eur Heart J"},{"key":"2025111708222466900_zwaf697-B22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2337\/dc23-1503","article-title":"Modifiable lifestyle factors, genetic risk, and incident peripheral artery disease among individuals with type 2 diabetes: a prospective study","volume":"47","author":"Zhu","year":"2024","journal-title":"Diabetes Care"},{"key":"2025111708222466900_zwaf697-B23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","article-title":"Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999\u20132000","volume":"110","author":"Selvin","year":"2004","journal-title":"Circulation"},{"key":"2025111708222466900_zwaf697-B24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"G\u00e6de","year":"2003","journal-title":"N Engl J Med"},{"key":"2025111708222466900_zwaf697-B25","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S2213-8587(17)30327-3","article-title":"Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial","volume":"5","author":"Ueki","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025111708222466900_zwaf697-B26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacc.2019.05.049","article-title":"Cigarette smoking, smoking cessation, and long-term risk of 3 major atherosclerotic diseases","volume":"74","author":"Ding","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2025111708222466900_zwaf697-B27","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/CIR.0000000000000623","article-title":"Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Treat-Jacobson","year":"2019","journal-title":"Circulation"},{"key":"2025111708222466900_zwaf697-B28","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1161\/CIRCULATIONAHA.118.033348","article-title":"Association of blood pressure measurements with peripheral artery disease events","volume":"138","author":"Itoga","year":"2018","journal-title":"Circulation"},{"key":"2025111708222466900_zwaf697-B29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.ackd.2014.07.005","article-title":"Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes","volume":"21","author":"Garimella","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"2025111708222466900_zwaf697-B30","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/CIRCULATIONAHA.118.037885","article-title":"Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks","volume":"139","author":"Sattar","year":"2019","journal-title":"Circulation"},{"key":"2025111708222466900_zwaf697-B31","first-page":"342","article-title":"A hidden problem: peripheral artery disease in women","volume":"9","author":"Kavurma","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025111708222466900_zwaf697-B32","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/CIR.0000000000000343","article-title":"Sex differences in the cardiovascular consequences of diabetes mellitus: a scientific statement from the American Heart Association","volume":"132","author":"Regensteiner","year":"2015","journal-title":"Circulation"},{"key":"2025111708222466900_zwaf697-B33","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1007\/s00125-016-4065-6","article-title":"Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial","volume":"59","author":"G\u00e6de","year":"2016","journal-title":"Diabetologia"},{"key":"2025111708222466900_zwaf697-B34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jchf.2016.08.001","article-title":"Hypertension, obesity, diabetes, and heart failure-free survival: the Cardiovascular Disease Lifetime Risk Pooling Project","volume":"4","author":"Ahmad","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2025111708222466900_zwaf697-B35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2025111708222466900_zwaf697-B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2021.9883","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999\u20132018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"2025111708222466900_zwaf697-B37","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.amjcard.2019.05.035","article-title":"Control of cardiovascular risk factors among US adults with type 2 diabetes with and without cardiovascular disease","volume":"124","author":"Andary","year":"2019","journal-title":"Am J Cardiol"},{"key":"2025111708222466900_zwaf697-B38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2337\/dc23-1198","article-title":"Risk factors for and risk of peripheral artery disease in Swedish individuals with type 2 diabetes: a nationwide register-based study","volume":"47","author":"Avdic","year":"2024","journal-title":"Diabetes Care"},{"key":"2025111708222466900_zwaf697-B39","doi-asserted-by":"crossref","first-page":"zwaf121","DOI":"10.1093\/eurjpc\/zwaf121","article-title":"Socioeconomic status, cardiovascular risk factors and coronary atherosclerosis: a SCOT-HEART trial analysis","author":"Weir-McCall","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"2025111708222466900_zwaf697-B40","doi-asserted-by":"crossref","first-page":"e576","DOI":"10.1016\/S2468-2667(18)30200-7","article-title":"The effect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective analysis of the UK Biobank cohort","volume":"3","author":"Foster","year":"2018","journal-title":"Lancet Public Health"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf697\/65050378\/zwaf697.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf697\/65050378\/zwaf697.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T13:22:32Z","timestamp":1763385752000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article\/doi\/10.1093\/eurjpc\/zwaf697\/8307543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaf697","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"zwaf697"}}